ROCK SPRINGS CAPITAL MANAGEMENT LP – PhaseBio Pharmaceuticals, Inc. Transaction History
ROCK SPRINGS CAPITAL MANAGEMENT LP portfolio value:
$479,000
portfolio value
ROCK SPRINGS CAPITAL MANAGEMENT LP quarter portfolio value change:
-70.66%
quarter
PhaseBio Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.01% | -55.79K shares | -1.18M | $0.18 | 2.71M |
| Q2 2022 | share | Increase | +6.16% | 161.04K shares | -1.78M | $0.6 | 2.77M |
| Q1 2022 | share | Increase | +1.26% | 32.52K shares | -3.28M | $1.32 | 2.61M |
| Q4 2021 | share | Increase | +40.00% | 737.53K shares | 1.00M | $2.62 | 2.58M |
| Q3 2021 | share | 0.00% | 0 shares | -1.12M | $3.11 | 1.84M | |
| Q2 2021 | share | Increase | +18.65% | 289.79K shares | 1.48M | $3.72 | 1.84M |
| Q1 2021 | share | Increase | +18.23% | 239.6K shares | 961K | $3.46 | 1.55M |
| Q4 2020 | share | Increase | +0.09% | 1.2K shares | -193K | $3.36 | 1.31M |
| Q3 2020 | share | Increase | +14.80% | 169.24K shares | -653K | $3.51 | 1.31M |
| Q2 2020 | share | Increase | +1.68% | 18.92K shares | 1.53M | $4.6 | 1.14M |
| Q1 2020 | share | 0.00% | 0 shares | -3.15M | $3.31 | 1.12M | |
| Q4 2019 | share | Decrease | -20.60% | -291.9K shares | 966K | $6.11 | 1.12M |
| Q3 2019 | share | Decrease | -0.45% | -6.35K shares | -12.76M | $4.17 | 1.41M |
| Q2 2019 | share | Increase | +24.85% | 283.25K shares | 7.83M | $13.12 | 1.42M |
| Q1 2019 | share | Increase | +36.53% | 305K shares | 8.26M | $9.51 | 1.14M |
| Q4 2018 | share | Increase | 0.00% | 835K shares | 2.58M | $3.09 | 835K |